216 related articles for article (PubMed ID: 34707960)
21. Clinical application of reverse-transcription polymerase chain reaction and intravenous immunoglobulin for enterovirus encephalitis.
Cheng MF; Chen BC; Huang TS; Hsieh KS; Chen SN; Liu YC
Jpn J Infect Dis; 2008 Jan; 61(1):18-24. PubMed ID: 18219129
[TBL] [Abstract][Full Text] [Related]
22. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
Servais S; Caers J; Warling O; Frusch N; Baron F; De Prijck B; Beguin Y
Br J Haematol; 2010 Aug; 150(3):379-81. PubMed ID: 20408837
[No Abstract] [Full Text] [Related]
23. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review.
Misbah SA; Spickett GP; Ryba PC; Hockaday JM; Kroll JS; Sherwood C; Kurtz JB; Moxon ER; Chapel HM
J Clin Immunol; 1992 Jul; 12(4):266-70. PubMed ID: 1512300
[TBL] [Abstract][Full Text] [Related]
24. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
Otremba MD; Adam SI; Price CC; Hohuan D; Kveton JF
Am J Otolaryngol; 2012; 33(5):619-22. PubMed ID: 22361345
[TBL] [Abstract][Full Text] [Related]
25. Enteroviral encephalitis presenting as rapidly progressive aphasia.
Kim KW; Ahn SW; Park KY; Youn YC; Shin HW
J Neurol Sci; 2012 Aug; 319(1-2):156-7. PubMed ID: 22632779
[TBL] [Abstract][Full Text] [Related]
26. Enteroviral meningitis in infancy: potential role for polymerase chain reaction in patient management.
Schlesinger Y; Sawyer MH; Storch GA
Pediatrics; 1994 Aug; 94(2 Pt 1):157-62. PubMed ID: 8036066
[TBL] [Abstract][Full Text] [Related]
27. Enterovirus 71 meningoencephalitis during chemotherapy in a child with metastatic osteosarcoma.
Frange P; Michon J; Fromantin I; Franck N; Safar E; Escande MC; Desguerre I; Orbach D
J Pediatr Hematol Oncol; 2007 Aug; 29(8):566-8. PubMed ID: 17762499
[TBL] [Abstract][Full Text] [Related]
28. Disseminated Enteroviral Infection Associated with Obinutuzumab.
Dendle C; Gilbertson M; Korman TM; Golder V; Morand E; Opat S
Emerg Infect Dis; 2015 Sep; 21(9):1661-3. PubMed ID: 26291712
[TBL] [Abstract][Full Text] [Related]
29. A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia.
Valcour V; Haman A; Cornes S; Lawall C; Parsa AT; Glaser C; Yagi S; Tihan T; Bhatnagar J; Geschwind M;
Nat Clin Pract Neurol; 2008 Jul; 4(7):399-403. PubMed ID: 18477991
[TBL] [Abstract][Full Text] [Related]
30. Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis.
Nigrovic LE; Chiang VW
Arch Pediatr Adolesc Med; 2000 Aug; 154(8):817-21. PubMed ID: 10922279
[TBL] [Abstract][Full Text] [Related]
31. Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia.
Kasahara Y; Imamura M; Shin C; Shimizu H; Utsumi J; Hosokai R; Iwabuchi H; Takachi T; Kakita A; Kanegane H; Saitoh A; Imai C
Front Pediatr; 2020; 8():579. PubMed ID: 33042921
[TBL] [Abstract][Full Text] [Related]
32. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.
Casulo C; Maragulia J; Zelenetz AD
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):106-11. PubMed ID: 23276889
[TBL] [Abstract][Full Text] [Related]
33. Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction.
Quartier P; Foray S; Casanova JL; Hau-Rainsard I; Blanche S; Fischer A
Pediatr Infect Dis J; 2000 Nov; 19(11):1106-8. PubMed ID: 11099099
[No Abstract] [Full Text] [Related]
34. Rheumatoid disease: an unusual cause of relapsing meningoencephalitis.
Alexander SK; Di Cicco M; Pohl U; Cifelli A
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29330273
[TBL] [Abstract][Full Text] [Related]
35. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
[TBL] [Abstract][Full Text] [Related]
36. Rituximab for the treatment of rheumatoid arthritis: an update.
Mok CC
Drug Des Devel Ther; 2013 Dec; 8():87-100. PubMed ID: 24403823
[TBL] [Abstract][Full Text] [Related]
37. West Nile virus neuroinvasive disease associated with rituximab therapy.
Owens M; Choe L; Rivera JE; Avila JD
J Neurovirol; 2020 Aug; 26(4):611-614. PubMed ID: 32472356
[TBL] [Abstract][Full Text] [Related]
38. [A case of agammaglobulinemia with chronic enteroviral meningomyelitis].
Ito N; Kokubo Y; Narita Y; Naito Y; Kuzuhara S
Rinsho Shinkeigaku; 1996 Feb; 36(2):306-11. PubMed ID: 8752685
[TBL] [Abstract][Full Text] [Related]
39. Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.
Giraud C; Tatar Z; Soubrier M
Clin Rheumatol; 2016 Oct; 35(10):2615-8. PubMed ID: 27541023
[TBL] [Abstract][Full Text] [Related]
40. Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study.
Boleto G; Avouac J; Wipff J; Forien M; Dougados M; Roux C; Kahan A; Dieude P; Allanore Y
Semin Arthritis Rheum; 2018 Oct; 48(2):149-154. PubMed ID: 29548542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
